Compound details
Lagumicine
| Compound ID | CDAMM02567 |
|---|---|
| Common name | Lagumicine | IUPAC name | methyl 12-acetyl-12-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carboxylate |
| Molecular formula | C20H22N2O4 |
| Retention time | 4.07 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 355.164 | Theoretical mz | 355.165 |
| Error | 3.31 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.8036 |
| Inchi key | KTEDEOXQNICGRJ-DCMZKIDVNA-N |
|---|---|
| Smiles | O=C(OC)C1=C2NC=3C=CC=CC3C24CCN5CC(O)(C(=O)C)C1CC54 |
| Superclass | Alkaloids and derivatives |
| Class | Strychnos alkaloids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9Y5N1 | HRH3 | Histamine H3 receptor | T64765 | SwissTargetPrediction |
| P08173 | CHRM4 | Muscarinic acetylcholine receptor M4 | T20709 | SwissTargetPrediction |
| P08912 | CHRM5 | Muscarinic acetylcholine receptor M5 | T79961 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SwissTargetPrediction |
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SwissTargetPrediction |
| P10635 | CYP2D6 | Cytochrome P450 2D6 | T57392 | SwissTargetPrediction |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SwissTargetPrediction |
| Q96KS0 | EIT6 | HIF-prolyl hydroxylase 1 | T53904 | SwissTargetPrediction |
| P00734 | F2 | Thrombin | T94033 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P27487 | DPP4 | Dipeptidyl peptidase IV | T31391 | SwissTargetPrediction |
| P98170 | XIAP | Inhibitor of apoptosis protein 3 | T16769 | SwissTargetPrediction |
| P55210 | CASP7 | Caspase-7 | T72252 | SwissTargetPrediction |
| O60341 | KDM1A | Lysine-specific histone demethylase 1 | T16739 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P28222 | HTR1B | Serotonin 1b (5-HT1b) receptor | T07806 | SwissTargetPrediction |
| P08588 | ADRB1 | Beta-1 adrenergic receptor | T44068 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| P34969 | HTR7 | Serotonin 7 (5-HT7) receptor | T79062 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| P11086 | PNMT | Phenylethanolamine N-methyltransferase | T56496 | SwissTargetPrediction |
| Q99705 | MCHR1 | Melanin-concentrating hormone receptor 1 | T09572 | SwissTargetPrediction |
| P12955 | PEPD | Xaa-Pro dipeptidase | T94823 | SwissTargetPrediction |
| Q9H3N8 | HRH4 | Histamine H4 receptor | T26500 | SwissTargetPrediction |
| P14902 | IDO1 | Indoleamine 2,3-dioxygenase | T89697 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction |
| P07550 | ADRB2 | Adrenergic receptor beta | T52522 | SwissTargetPrediction |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SwissTargetPrediction |
| P13945 | ADRB3 | Beta-3 adrenergic receptor | T51408 | SwissTargetPrediction |
| Q13639 | HTR4 | Serotonin 4 (5-HT4) receptor | T59679 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| P25100 | ADRA1D | Alpha-1d adrenergic receptor | T53381 | SwissTargetPrediction |
| P35368 | ADRA1B | Alpha-1b adrenergic receptor | T29500 | SwissTargetPrediction |
| P41145 | OPRK1 | Kappa Opioid receptor | T60693 | SwissTargetPrediction |
| P04626 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | T14597 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| P00742 | F10 | Thrombin and coagulation factor X | T84631 | SwissTargetPrediction |
| Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | T35173 | SwissTargetPrediction |
| Q13490 | BIRC2 | Baculoviral IAP repeat-containing protein 2 | T84780 | SwissTargetPrediction |
| Q9UHL4 | DPP7 | Dipeptidyl peptidase II | T50773 | SwissTargetPrediction |
| Q13418 | ILK | Serine/threonine-protein kinase ILK-1 | T13616 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| Q14432 | PDE3A | Phosphodiesterase 3 | T88975 | SwissTargetPrediction |
| P29466 | CASP1 | Caspase-1 | T98269 | SwissTargetPrediction |
| Q12884 | FAP | Fibroblast activation protein alpha (by homology) | T53764 | SwissTargetPrediction |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| P50579 | METAP2 | Methionine aminopeptidase 2 | T75596 | SwissTargetPrediction |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SwissTargetPrediction |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| P23443 | RPS6KB1 | Ribosomal protein S6 kinase 1 | T94479 | SwissTargetPrediction |
| P49840 | GSK3A | Glycogen synthase kinase-3 alpha | T76910 | SwissTargetPrediction |
| P41146 | OPRL1 | Nociceptin receptor | T52921 | SwissTargetPrediction |
| Q9UQ81 | MCH5 | Caspase-8 | T15700 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| Q6V1X1 | DPP8 | Dipeptidyl peptidase VIII | T15855 | SwissTargetPrediction |
| P48067 | SLC6A9 | Glycine transporter 1 | T69685 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| Q14524 | SCN5A | Sodium channel protein type V alpha subunit | T39716 | SwissTargetPrediction |
| P22460 | KCNA5 | Voltage-gated potassium channel subunit Kv1.5 | T17569 | SwissTargetPrediction |
| Q07343 | PDE4B | Phosphodiesterase 4B (by homology) | T10265 | SwissTargetPrediction |
| P07948 | LYN | Tyrosine-protein kinase Lyn | T68163 | SwissTargetPrediction |
| Q99873 | PRMT1 | Protein-arginine N-methyltransferase 1 | T16808 | SwissTargetPrediction |
| P43403 | ZAP70 | Tyrosine-protein kinase ZAP-70 | T64553 | SwissTargetPrediction |
| Q13224 | GRIN2B | Glutamate [NMDA] receptor subunit epsilon 2 | T76414 | SwissTargetPrediction |
| P63316 | TNNC1 | Troponin, cardiac muscle | T12966 | SwissTargetPrediction |
| Q13126 | MTAP | S-methyl-5-thioadenosine phosphorylase | T40787 | SwissTargetPrediction |
| P53634 | CTSC | Dipeptidyl peptidase I | T70490 | SwissTargetPrediction |
| Q15119 | PDK2 | Pyruvate dehydrogenase kinase isoform 2 | T17967 | SEA |
| Q9HCR9 | PDE11A | Phosphodiesterase 11A | T99802 | SwissTargetPrediction |
| Q8NET8 | TRPV3 | Transient receptor potential cation channel subfamily V member 3 | T58496 | SwissTargetPrediction |
| Q96PY6 | NEK1 | Serine/threonine-protein kinase Nek1 | T43031 | SwissTargetPrediction |
| Q9UIF9 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | T95682 | SwissTargetPrediction |
| O43895 | XPNPEP2 | Xaa-Pro aminopeptidase 2 | T68320 | SwissTargetPrediction |
| Q9UIF8 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | T15745 | SwissTargetPrediction |
| Q969V1 | MCHR2 | Melanin-concentrating hormone receptor | T70539 | SEA |
| Q9GZT9 | EGLN1 | Egl nine homolog 1 | T32880 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T64765 | DI0392 | Somnolence | [ICD-11: MG42] | Q9Y5N1 | HRH3 |
| T20709 | DI0037 | Asthma | [ICD-11: CA23] | P08173 | CHRM4 |
| T20709 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | P08173 | CHRM4 |
| T20709 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08173 | CHRM4 |
| T20709 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P08173 | CHRM4 |
| T20709 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08173 | CHRM4 |
| T79961 | DI0002 | Abnormal micturition | [ICD-11: MF50] | P08912 | CHRM5 |
| T79961 | DI0032 | Anterior uveitis | [ICD-11: 9A96] | P08912 | CHRM5 |
| T79961 | DI0034 | Appearance/behaviour symptom | [ICD-11: MB23] | P08912 | CHRM5 |
| T79961 | DI0037 | Asthma | [ICD-11: CA23] | P08912 | CHRM5 |
| T79961 | DI0061 | Brain disease | [ICD-11: 8C70-8E61] | P08912 | CHRM5 |
| T79961 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08912 | CHRM5 |
| T79961 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08912 | CHRM5 |
| T79961 | DI0093 | Cognition symptoms/signs/clinical symptom | [ICD-11: MB21] | P08912 | CHRM5 |
| T79961 | DI0105 | Cough | [ICD-11: MD12] | P08912 | CHRM5 |
| T79961 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P08912 | CHRM5 |
| T79961 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P08912 | CHRM5 |
| T79961 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P08912 | CHRM5 |
| T79961 | DI0158 | Gastritis | [ICD-11: DA42] | P08912 | CHRM5 |
| T79961 | DI0162 | General examination | [ICD-11: QA00] | P08912 | CHRM5 |
| T79961 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08912 | CHRM5 |
| T79961 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08912 | CHRM5 |
| T79961 | DI0208 | Infectious gastroenteritis/colitis | [ICD-11: 1A40] | P08912 | CHRM5 |
| T79961 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P08912 | CHRM5 |
| T79961 | DI0307 | Nystagmus | [ICD-11: 9C84] | P08912 | CHRM5 |
| T79961 | DI0315 | Oesophagus motility disorder | [ICD-11: DA21] | P08912 | CHRM5 |
| T79961 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P08912 | CHRM5 |
| T79961 | DI0329 | Pancreatitis | [ICD-11: DC31-DC34] | P08912 | CHRM5 |
| T79961 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P08912 | CHRM5 |
| T79961 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08912 | CHRM5 |
| T79961 | DI0338 | Polyuria | [ICD-11: MF55] | P08912 | CHRM5 |
| T79961 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P08912 | CHRM5 |
| T79961 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P08912 | CHRM5 |
| T79961 | DI0424 | Urgency | [ICD-11: N.A.] | P08912 | CHRM5 |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T57392 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P10635 | CYP2D6 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T53904 | DI0010 | Acute disease anaemia | [ICD-11: 3A90] | Q96KS0 | EIT6 |
| T94033 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00734 | F2 |
| T94033 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00734 | F2 |
| T94033 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P00734 | F2 |
| T94033 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P00734 | F2 |
| T94033 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00734 | F2 |
| T94033 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00734 | F2 |
| T94033 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P00734 | F2 |
| T94033 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00734 | F2 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T31391 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P27487 | DPP4 |
| T31391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P27487 | DPP4 |
| T16769 | DI0259 | Metastatic lymph node neoplasm | [ICD-11: 2D60] | P98170 | XIAP |
| T72252 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P55210 | CASP7 |
| T16739 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O60341 | KDM1A |
| T16739 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O60341 | KDM1A |
| T16739 | DI0138 | Ewing sarcoma | [ICD-11: 2B52] | O60341 | KDM1A |
| T16739 | DI0238 | Lung cancer | [ICD-11: 2C25] | O60341 | KDM1A |
| T16739 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O60341 | KDM1A |
| T16739 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O60341 | KDM1A |
| T16739 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O60341 | KDM1A |
| T16739 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60341 | KDM1A |
| T16739 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O60341 | KDM1A |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T07806 | DI0264 | Migraine | [ICD-11: 8A80] | P28222 | HTR1B |
| T07806 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28222 | HTR1B |
| T07806 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P28222 | HTR1B |
| T07806 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28222 | HTR1B |
| T44068 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P08588 | ADRB1 |
| T44068 | DI0037 | Asthma | [ICD-11: CA23] | P08588 | ADRB1 |
| T44068 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | P08588 | ADRB1 |
| T44068 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08588 | ADRB1 |
| T44068 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P08588 | ADRB1 |
| T44068 | DI0097 | Conduction disorder | [ICD-11: BC63] | P08588 | ADRB1 |
| T44068 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P08588 | ADRB1 |
| T44068 | DI0137 | Essential hypertension | [ICD-11: BA00] | P08588 | ADRB1 |
| T44068 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08588 | ADRB1 |
| T44068 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08588 | ADRB1 |
| T44068 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08588 | ADRB1 |
| T44068 | DI0264 | Migraine | [ICD-11: 8A80] | P08588 | ADRB1 |
| T44068 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P08588 | ADRB1 |
| T44068 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P08588 | ADRB1 |
| T44068 | DI0434 | Ventricular tachyarrhythmia | [ICD-11: BC71] | P08588 | ADRB1 |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T79062 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P34969 | HTR7 |
| T79062 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34969 | HTR7 |
| T79062 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P34969 | HTR7 |
| T79062 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P34969 | HTR7 |
| T79062 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P34969 | HTR7 |
| T79062 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P34969 | HTR7 |
| T79062 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P34969 | HTR7 |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T09572 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q99705 | MCHR1 |
| T26500 | DI0037 | Asthma | [ICD-11: CA23] | Q9H3N8 | HRH4 |
| T26500 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9H3N8 | HRH4 |
| T26500 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9H3N8 | HRH4 |
| T26500 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9H3N8 | HRH4 |
| T26500 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q9H3N8 | HRH4 |
| T89697 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14902 | IDO1 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T52522 | DI0037 | Asthma | [ICD-11: CA23] | P07550 | ADRB2 |
| T52522 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07550 | ADRB2 |
| T52522 | DI0097 | Conduction disorder | [ICD-11: BC63] | P07550 | ADRB2 |
| T52522 | DI0344 | Preterm labour/delivery | [ICD-11: JB00] | P07550 | ADRB2 |
| T52522 | DI0387 | Sleep-related breathing disorder | [ICD-11: 7A4Z] | P07550 | ADRB2 |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T51408 | DI0030 | Angina pectoris | [ICD-11: BA40] | P13945 | ADRB3 |
| T51408 | DI0037 | Asthma | [ICD-11: CA23] | P13945 | ADRB3 |
| T51408 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13945 | ADRB3 |
| T51408 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P13945 | ADRB3 |
| T51408 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P13945 | ADRB3 |
| T51408 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P13945 | ADRB3 |
| T51408 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P13945 | ADRB3 |
| T59679 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | Q13639 | HTR4 |
| T59679 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q13639 | HTR4 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T53381 | DI0166 | Glaucoma | [ICD-11: 9C61] | P25100 | ADRA1D |
| T53381 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P25100 | ADRA1D |
| T53381 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25100 | ADRA1D |
| T53381 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P25100 | ADRA1D |
| T53381 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P25100 | ADRA1D |
| T53381 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25100 | ADRA1D |
| T29500 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P35368 | ADRA1B |
| T29500 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35368 | ADRA1B |
| T29500 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P35368 | ADRA1B |
| T29500 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35368 | ADRA1B |
| T29500 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35368 | ADRA1B |
| T60693 | DI0304 | Non-specific cutaneous vascular symptom | [ICD-11: ME64] | P41145 | OPRK1 |
| T60693 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41145 | OPRK1 |
| T60693 | DI0349 | Pruritus | [ICD-11: EC90] | P41145 | OPRK1 |
| T14597 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P04626 | ERBB2 |
| T14597 | DI0238 | Lung cancer | [ICD-11: 2C25] | P04626 | ERBB2 |
| T14597 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P04626 | ERBB2 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T84631 | DI0053 | Blood-forming organ disease | [ICD-11: 3C0Z] | P00742 | F10 |
| T84631 | DI0080 | Christmas disease | [ICD-11: 3B11] | P00742 | F10 |
| T84631 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00742 | F10 |
| T84631 | DI0103 | Coronary thrombosis | [ICD-11: BA43] | P00742 | F10 |
| T84631 | DI0114 | Deep vein thrombosis | [ICD-11: BD71] | P00742 | F10 |
| T84631 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P00742 | F10 |
| T84631 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00742 | F10 |
| T84631 | DI0433 | Venous thromboembolism | [ICD-11: BD72] | P00742 | F10 |
| T35173 | DI0259 | Metastatic lymph node neoplasm | [ICD-11: 2D60] | Q13489 | BIRC3 |
| T84780 | DI0259 | Metastatic lymph node neoplasm | [ICD-11: 2D60] | Q13490 | BIRC2 |
| T13616 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q13418 | ILK |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T88975 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q14432 | PDE3A |
| T88975 | DI0037 | Asthma | [ICD-11: CA23] | Q14432 | PDE3A |
| T88975 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q14432 | PDE3A |
| T88975 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | Q14432 | PDE3A |
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T53764 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q12884 | FAP |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T75596 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50579 | METAP2 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T94479 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P23443 | RPS6KB1 |
| T94479 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P23443 | RPS6KB1 |
| T94479 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P23443 | RPS6KB1 |
| T76910 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P49840 | GSK3A |
| T52921 | DI0039 | Atopic eczema | [ICD-11: EA80] | P41146 | OPRL1 |
| T52921 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41146 | OPRL1 |
| T52921 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P41146 | OPRL1 |
| T52921 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41146 | OPRL1 |
| T15700 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | Q9UQ81 | MCH5 |
| T15700 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQ81 | MCH5 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T15855 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q6V1X1 | DPP8 |
| T69685 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P48067 | SLC6A9 |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T39716 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q14524 | SCN5A |
| T39716 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q14524 | SCN5A |
| T39716 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q14524 | SCN5A |
| T39716 | DI0105 | Cough | [ICD-11: MD12] | Q14524 | SCN5A |
| T39716 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | Q14524 | SCN5A |
| T39716 | DI0264 | Migraine | [ICD-11: 8A80] | Q14524 | SCN5A |
| T39716 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q14524 | SCN5A |
| T39716 | DI0434 | Ventricular tachyarrhythmia | [ICD-11: BC71] | Q14524 | SCN5A |
| T17569 | DI0030 | Angina pectoris | [ICD-11: BA40] | P22460 | KCNA5 |
| T10265 | DI0037 | Asthma | [ICD-11: CA23] | Q07343 | PDE4B |
| T10265 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q07343 | PDE4B |
| T10265 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q07343 | PDE4B |
| T68163 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | P07948 | LYN |
| T68163 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P07948 | LYN |
| T16808 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99873 | PRMT1 |
| T76414 | DI0024 | Alpha-1-antitrypsin deficiency | [ICD-11: 5C5A] | Q13224 | GRIN2B |
| T12966 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P63316 | TNNC1 |
| T12966 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P63316 | TNNC1 |
| T40787 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q13126 | MTAP |
| T70490 | DI0064 | Bronchiectasis | [ICD-11: CA24] | P53634 | CTSC |
| T17967 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q15119 | PDK2 |
| T58496 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q8NET8 | TRPV3 |